Articles dans des revues avec comité de lecture (364)

  1. 238. Trenschel, R., Bernier, M., Delforge, A., Massy, M., Lebeau De Hemricourt, E., Maerevoet, M., Badjou, R., Stryckmans, P., & Bron, D. (1998). Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation. Leukemia & lymphoma, 30(3-4), 325-352.
  2. 239. Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C., & Stryckmans, P. (1998). Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood, 91(7), 2387-2396.
  3. 240. Mateo, V., Lagneaux, L., Bron, D., & Sarfati, M. (1998). Induction of apoptosis in B-cells from chronic lymphocytic leukemia (B-CLLS) by CD47. The FASEB journal, 12(5), A1082.
  4. 241. Roufosse, C., Lespagnard, L., Sales, F., Bron, D., & Dargent, J.-L. (1998). Langherhan’s cell histiocytosis associated with simultaneous lymphocyte predominance hodgkin’s disease and malignant melanoma. Human pathology, 29(2), 200-201.
  5. 242. Bron, D. (1998). Euthanasia, four propositions of the Consultant Committee on Bioethics. Revue médicale de Bruxelles, 19(4), A312-313.
  6. 243. Guglielmi, C., Gomez, F., Philip, T., Hagenbeek, A., Martelli, M., Sebban, C., Milpied, N., Bron, D., Cahn, J.-Y., Somers, R., Sonneveld, P., Gisselbrecht, C., Van der Lelie, H., & Chauvin, F. (1998). Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. Journal of clinical oncology, 16(10), 3264-3269.
  7. 244. Tirelli, U., Zagonel, V., van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, H. C., Thomas, J., Bron, D., Somers, R., Errante, D., & Noordijk, E. M. (1998). CHOP is the standard regimen in patients 70 years of age with intermediate-grade and high-grade non-Hodgkin’s lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma cooperative study group. Journal of clinical oncology, 16, 27-34.
  8. 245. Bleiberg, H., Duchateau, J., N'Koua Mbon, J. B., Gérard, B., Bron, D., Debusscher, L., & Stryckmans, P. (1998). Increased incidence of lymphomas and carcinomas in patients with coeliac disease. European journal of cancer, 34(4), 592-593.
  9. 246. De Bruyn, C., Delforge, A., & Bron, D. (1998). Stem cell factor and interleukjn 3 receptor expression on CD34+CD38+ ANDCD34+CD38+ cells from umbilical cord blood and mobilized peripheral blood. Experimental hematology, 26(8), 735.
  10. 247. Bron, D. (1998). Euthanasie: les quatre propositions du Comité Consultatif de Bioéthique. Revue médicale de Bruxelles, 19(4), A312-313.
  11. 248. Lagneaux, L., Delforge, A., Bron, D., Massy, M., Bernier, M., & Stryckmans, P. (1997). Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors. British journal of haematology, 97(3), 612-620. doi:10.1046/j.1365-2141.1997.792715.x
  12. 249. De Bruyn, C., Delforge, A., Bron, D., Bernier, M., Massy, M., De Hemptinne, D., & Stryckmans, P. (1997). Ex vivo expansion of CD34 + CD38- cord blood cells. Journal of hematotherapy, 6(2), 93-102.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>